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Joint formation, the onset of which is characterized by the segmentation of continuous skeletal rudiments into two or more
separate elements, is a fundamental aspect of limb pattern formation, playing a critical role in determining the size, shape,
and number of individual skeletal elements. Joint formation is initiated by conversion of differentiated chondrocytes at sites
of presumptive joints into densely packed nonchondrogenic cells of the joint interzone. This conversion is accompanied by
loss of Alcian blue-staining cartilage matrix and downregulation of cartilage-specific gene expression. Here, we report that
Cux1, which encodes a transcription factor containing a homeodomain and other DNA-binding motifs, is highly expressed
at all of the discrete sites of incipient joint formation in the developing limb concomitant with conversion of differentiated
chondrocytes into interzone tissue. Moreover, differentiated limb chondrocytes in micromass cultures infected with a Cux1
retroviral expression vector are converted into nonchondrogenic cells which exhibit loss of Alcian blue cartilage matrix and
downregulation of cartilage-specific gene expression as occurs at the onset of normal joint formation. These results suggest
that Cux1 is involved in regulating the onset of joint formation by facilitating conversion of chondrocytes into
nonchondrogenic cells of the interzone. © 2002 Elsevier Science (USA)
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The formation of synovial (diarthrodial) joints plays a
critical role in the patterning of the skeletal elements of the
developing vertebrate limb. The various skeletal elements
of the limb do not initially develop as discrete individual
rudiments, but rather initially form as continuous entities
which are subsequently divided into distinct segments as a
result of joint formation. For example, the humerus, radius,
and ulna rudiments are initially formed as a continuous
uninterrupted Y-shaped unit in which the radius and ulna
branch from the humerus. The separation of this single
Y-shaped rudiment into three distinct skeletal elements is
dependent on the formation of the elbow joint between the
distal end of the humerus and proximal ends of the radius
and ulna. Similar segmentation processes occur during the
formation of the individual carpal/tarsal rudiments and the
individual metacarpal/metatarsal and phalangeal rudi-
1 To whom correspondence should be addressed. Fax: (860) 679-
2910. E-mail: kosher@neuron.uchc.edu.
44ments. Thus, the segmentation of continuous skeletal ru-
diments into two or more separate elements is one of the
fundamental aspects of limb pattern formation (Shubin and
Alberch, 1986). This process plays a critical role in deter-
mining the size, shape, and number of individual skeletal
elements (Shubin and Alberch, 1986).
The onset of the segmentation process that generates
joints between the skeletal elements of the limb is charac-
terized by the conversion of differentiated chondrocytes at
the site of the presumptive joint into a narrow band of
densely packed flattened cells called the joint interzone
(Mitrovic, 1977, 1978; Archer et al., 1994; Francis-West et
al., 1999b). The conversion of differentiated chondrocytes
into joint interzone cells is accompanied by a loss of Alcian
blue-staining cartilage matrix at sites of presumptive joint
formation and a striking diminution in expression of
cartilage-characteristic type II collagen and other cartilage-
specific genes. For example, Alcian blue stainable cartilage
matrix and high level expression of type II collagen are
present throughout the continuous Y-shaped humerus, ra-
dius, and ulna rudiment, including the site at which the
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elbow joint will subsequently form, and Alcian blue stain-
ing and type II collagen expression greatly diminish con-
comitant with the formation of the interzone of the future
elbow joint (Koyama et al., 1995; see also Fig. 3 in Results).
Similarly, digits form as continuous rods of cartilage char-
acterized by high level type II collagen expression which are
subsequently divided into separate elements by the forma-
tion of joint interzones which exhibit little type II collagen
expression (Craig et al., 1987). Thus, the onset of joint
formation is characterized by the conversion of differenti-
ated chondrocytes that stain with Alcian blue and express
high amounts of type II collagen into the densely packed
nonchondrogenic flattened cells constituting the interzone
which exhibit little or no Alcian blue staining or type II
collagen expression.
Despite the importance of joint formation in the patterning
of the skeletal elements of the limbs and its clinical relevance
to degenerative joint diseases, relatively little is known about
the genes, signaling molecules, and cellular and molecular
mechanisms involved in the regulation of early joint forma-
tion. A secreted signaling molecule that plays an important
role in joint formation is growth and differentiation factor-5
(Gdf5), a member of the transforming growth factor- (TGF-)
superfamily that is closely related to bone morphogenetic
proteins (BMPs). Gdf5 is expressed at virtually all of the sites
at which synovial joints will form between the skeletal
elements of the limb (Storm and Kingsley, 1996; Wolfman et
al., 1997; Merino et al., 1999; Francis-West et al., 1999a), and
null or loss-of-function mutations in Gdf5 result in aberrant
joint formation in mice and humans (Storm and Kingsley,
1996; Thomas et al., 1996, 1997; Polinkovsky et al., 1997).
The mechanism by which Gdf5 regulates joint formation is,
however, unknown, and misexpression of Gdf5 does not cause
ectopic joint formation in limb skeletal elements (Francis-
West et al., 1999a; Merino et al., 1999; Storm and Kings-
ley,1999).
Another signaling molecule that has recently been impli-
cated in the regulation of the onset of joint formation is
Wnt14, a member of the Wnt/wingless family of secreted
signaling molecules. Wnt14 is expressed at the sites of forma-
tion of the presumptive interphalangeal joints in the develop-
ing hind limb of the chick embryo (Hartmann and Tabin,
2001). Misexpression of Wnt14 converts differentiating limb
cartilage into nonchondrogenic tissue which expresses Gdf5
and other molecular markers of early joint formation (Hart-
mann and Tabin, 2001). Thus, it has been suggested that
Wnt14 may play a key role in initiating joint formation in the
developing limb (Hartmann and Tabin, 2001).
In the present study, we provide evidence implicating the
homeobox-containing gene Cux1, a homolog of the Dro-
sophila Cut gene (Jack et al., 1991; Blochinger et al., 1993),
in the regulation of the onset of joint formation in the
developing chick limb. Vertebrate Cux1 homologs of Cut
(variously called CDP/Cut, Cux/CDP, Clox, CDP2, and
Cux1), like the fly gene, encode large transcription factors
(about 200 kb) that contain a single homeodomain and two
to three novel DNA-binding motifs about 70 amino acids in
length called cut repeats (Neufeld et al., 1992; Vanden
Heuvel et al., 1996; Valarche et al., 1993; Andres et al.,
1992; Yoon and Chikaraishi, 1996; Tavares et al., 2000).
The Drosophila Cut gene is required for the formation of
the fly wing margin, which plays a crucial role in fly limb
outgrowth and patterning (Jack et al., 1991; Blochinger et
al., 1993; Ludlow et al., 1996). Recently, Cux1 has also been
implicated in the formation of the apical ectodermal ridge
(AER), a signaling center that directs the outgrowth and
patterning of the vertebrate limb bud (Tavares et al., 2000).
Here, we report that Cux1 is highly expressed at all of the
discrete sites of incipient joint formation in the developing
limb concomitant with the conversion of differentiated
chondrocytes into interzone tissue. We further demonstrate
that retroviral misexpression of Cux1 elicits a conversion of
differentiated limb chondrocytes into nonchondrogenic
cells which exhibit loss of Alcian blue cartilage matrix and
downregulation of cartilage-specific gene expression as oc-
curs during the onset of normal joint formation. These
studies suggest that Cux1 is involved in regulating the
onset of joint formation by facilitating the conversion of
differentiated chondrocytes into the nonchondrogenic cells
of the joint interzone.
MATERIALS AND METHODS
Hybridization Probes
A 2393-bp chicken cerebellum EST cDNA clone (GenBank
Accession No. T25685) in pUEX1 encoding a highly conserved
alternatively spliced product of the Cux1 gene called CASP (CDP/
cut alternatively spliced product) (see Lievens et al., 1997) was
provided by Dr. William Jefferies. A 993-bp fragment corresponding
to the 5 end of this clone (T25685) was prepared by digesting with
BamHI and Bgl2, and cloned into the BamHI site of the Bluescript
SK vector. A 993-bp hybridization probe was prepared by digest-
ing with BamHI and SpeI. The 60 nucleotides at the 5 end of this
993-bp fragment encode a 20-amino-acid sequence unique to the N
terminus of CASP, whereas the remainder of the fragment contains
933 bp of coding sequence present in both full-length Cux1
transcripts and in CASP (Lievens et al., 1997). Therefore, this probe
would hybridize to both full-length Cux1 transcripts containing
the homeobox and the DNA-binding cut repeats and to CASP, the
small alternatively spliced product of the Cux1 gene that lacks
DNA-binding motifs.
A cDNA probe that would specifically hybridize to Cux1 tran-
scripts and not to either CASP or Cux2, the only other member of
the vertebrate Cut family (Quaggin et al., 1996; Tavares et al.,
2000), was prepared by RT-PCR from total RNA isolated from stage
24/25 (Hamburger and Hamilton, 1951) chick embryos with the
RNeasy Mini kit (Qiagen). Specifically, degenerate primers were
used to amplify a 281-bp fragment of chicken Cux1 encompassing
122 nucleotides upstream of the homeobox and 159 nucleotides of
the 5 portion of the homeobox. The degenerate primers derived
from published mouse and human Cux1 nucleotide sequences
(Neufeld et al., 1992; Vanden Heuvel et al., 1996) were 5 primer,
5-ATGGA(A/G)AA(A/G)AA(A/G)GC(A/C/T/G)TA(C/T)ATG,
and 3-primer, 5-(C/G)(A/T)(A/CT/G)C(T/G)(A/G)TT(A/G)TG(A/
G)AACCA. The amplified 281-bp fragment was cloned into the
PCR Topo vector (Invitrogen) and sequenced. The deduced amino
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acid sequence encoded by the fragment was identical to the
corresponding region of chicken Cux1 (Taveres et al., 2000). To
ensure a highly specific Cux1 hybridization probe, the 281-bp
fragment isolated by RT-PCR was digested with BamHI and PvuII
to prepare a 122-bp hybridization probe located upstream of the
homeobox. This 122-bp fragment is specific for Cux1 and shares no
homology with CASP or Cux2.
A 741-bp cDNA probe that would specifically hybridize to CASP
was prepared from the 3 portion of chicken CASP cDNA by digesting
the 2393-bp cDNA clone (T25685) with BamHI and MluNI. This
741-bp cDNA fragment is unique to the C-terminal end of CASP and
shares no homology with Cux1 (Lievens et al., 1997).
A 328-bp Gdf5-specific hybridization probe corresponding to the
nonconserved 5 end of chicken Gdf5 cDNA was prepared by
digesting full-length chicken Gdf5 cDNA in Bluescript SK (pro-
vided by Dr. Frank Luyten) with EcoRI and AvaI. A 1.2-kb cDNA
probe corresponding to the entire coding sequence of chicken
Wnt14 cDNA was prepared by digesting full-length Wnt14 cDNA
in Bluescript SK/ (provided by Dr. A. M. C. Brown; see Bergstein
et al., 1997) with EcoRI. Probes specific for transcripts encoding
chicken type II collagen and the core protein of the cartilage
proteoglycan aggrecan were prepared as previously described (Nah
et al., 1988; Mallein-Gerin et al., 1988).
The cDNA probes were labeled with [33P]- or [32P]dCTP following
the random primer oligonucleotide procedure.
In Situ and Northern Blot Hybridization
In situ hybridization on serially sectioned limb buds that had
been fixed in Bouin’s solution was performed by using 33P-labeled
cDNA probes (see above) and high stringency hybridization condi-
tions as previously described (Coelho et al., 1991). In order to
carefully correlate expression patterns of different genes, in most
cases, adjacent sections (within 20 m of one another) of the same
limb buds were mounted on separate slides and hybridized with
different probes. Total RNA was isolated from stage 26/27, stage
29, and stage 30 limb buds (Hamburger and Hamilton, 1951) by
using the RNeasy Mini kit (Qiagen), and Northern blot analysis
was performed at high stringency by using 32P-labeled cDNA as
previously described (Dealy et al., 1993).
Preparation of a Cux1 Retroviral Expression Vector
A Moloney murine leukemia virus (MoMLV)-derived replica-
tion-defective retroviral vector was used for misexpression of a
4.6-kb cDNA containing the full coding sequence of human Cux1
(provided by Dr. Ellis Neufeld; see Neufeld et al., 1992). A
replication-defective vector was used for Cux1 misexpression,
since the large size of the Cux1 cDNA (4.6 kb) required a vector
that would express large cDNA inserts. In addition, the replication-
defective vector could be used to simultaneously express both
Cux1 cDNA and a cDNA encoding enhanced green fluorescent
protein (EGFP), a bright derivative of green fluorescent protein
which would serve as a marker to monitor expression of the vector
in living cells by fluorescence microscopy. The MoMLV-derived
replication-defective vector used for Cux1 misexpression is a
modified version of a vector called MG-1 (provided by Dr. David
Dorsky) which is a derivative of LXSN (Miller and Rosman, 1989)
into which a cytomegalovirus (CMV) promoter and an EGFP cDNA
had been cloned upstream of the simian virus 40 (SV40) promoter
and neomycin resistance (neo) gene cassette of the LXSN vector. In
preparation for construction of the Cux1 retroviral expression
vector, first, the modified MG-1 vector was prepared by excising a
1.86-kb fragment containing the EGFP cDNA, SV40 promoter, and
most of the neo gene by digestion with AgeI and RsrII (Fig. 1). This
resulted in a modified MG-1 vector called GL-1 containing an
internal CMV promoter (Fig. 1). Next, the 4.6-kb cDNA containing
the full coding sequence of human Cux1 was cloned by blunt-end
ligation into the SalI site of an pIRES2/EGFP vector (Clontech),
resulting in a construct containing Cux1 cDNA upstream of an
internal ribosome entry site (IRES) followed by an EGFP cDNA
(Fig. 1). The Cux1-IRES-EGFP fragment was excised by digestion
with EcoRV and NotI and cloned by blunt-end ligation into GL-1
downstream of the CMV promoter. This resulted in a retroviral
construct containing the CMV promoter upstream of the Cux1
cDNA followed by an IRES and an EGFP cDNA (Fig. 1). Thus, in
this construct, the CMV promoter drives expression of both Cux1
and EGFP, and the presence of the IRES between the two cDNAs
enables initiation of translation of the EGFP cDNA immediately
after translation of the Cux1 cDNA.
Stable retroviral vector-producing cell lines were generated by
using the vesicular stomatitis virus (VSV) pseudotype helper cell
line 293 GPG (Ory et al., 1996). For packaging, the Cux1/EGFP
retroviral construct, prepared as described above, was transfected
by use of the cationic lipid reagent Lipofectamine (Gibco BRL) into
VSV pseudotype helper cells 293 GPG plated at 50% confluence in
tetracycline-containing medium. The VSV envelope protein is
under the control of the Tet-Off system, since VSV is toxic to cells.
Therefore, following transfection, virus production was initiated by
the addition of medium lacking tetracycline. After 3–4 days of
culture, the retrovirus-containing medium was harvested, and the
virus was concentrated by ultracentrifugation as described by
Burns et al. (1993). To generate high-titer producer cell lines,
aliquots of the concentrated retrovirus and 4 g/ml polybrene (to
facilitate virus infection) were used to infect 293 GPG cells plated
at clonal densities. Three days after infection, single cells highly
expressing EGFP were detected by fluorescence microscopy. These
highly fluorescent cells were picked from the tissue culture dish
and used to establish the retroviral vector-producing cell lines. The
individual producer cells were initially grown in wells of a 24-well
tissue culture plate, and after reaching confluence were passaged
onto 100-mm tissue culture dishes. After reaching confluence in
the 100-mm tissue culture dishes, the virus-containing medium
was harvested, virus was concentrated by ultracentrifugation
(Burns et al., 1993), and aliquots were stored at 70°C.
Titers were determined essentially as described by Fekete and
Cepko (1993), by adding limiting dilutions of concentrated retrovi-
rus stock and polybrene to subconfluent cultures of chick embryo
fibroblasts (CEF) and counting EGFP-positive colonies to obtain the
number of cfu/ml. Retroviral titers ranged from 2 to 8  107.
To confirm that the retrovirus efficiently expressed Cux1 and
EGFP, subconfluent CEF cultures in 10 ml of medium were
infected with 20 l of concentrated retrovirus stock and polybrene.
After 72 h, the extent of EGFP expression was examined by
fluorescence microscopy and the expression of Cux1 was examined
by Western blotting by using an affinity-purified goat polyclonal
antibody against human Cux1 (CDP; Santa Cruz). Virtually all of
the CEFs expressed EGFP detectable by fluorescence microscopy.
In addition, Western blotting with the anti-Cux1 antibody of
protein lysates from CEFs infected with the Cux1 retrovirus
revealed a major band of about 200 kDa, which is the size expected for
human Cux1 protein (Neufeld et al., 1996). In contrast, no immuno-
reactive Cux1 protein was detected in Western blots of protein lysates
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from uninfected CEFs or from CEFs infected with control retrovirus
expressing EGFP but lacking the Cux1 cDNA insert.
Micromass Cultures: Preparation, Retroviral
Infection, and Analysis
Micromass cultures were prepared from the uniform population
of mesenchymal chondrogenic precursor cells of the distal tip of
stage 25 (Hamburger and Hamilton, 1951) embryonic chick wing
buds as previously described (Gay and Kosher, 1984). For retroviral
infection, 1–2 l of concentrated retrovirus stock (2–8 107cfu/ml;
see above) and 0.1 l of polybrene (to facilitate virus infection) were
added per 10 l of a cell suspension containing 2  107 cells/ml,
after which 10-l drops of the cell suspension (2  105 cells) were
dispensed onto the surface of 35-mm tissue culture dishes (Ahrens
et al., 1977; Gay and Kosher, 1984). The retrovirus-containing
micromass cultures were then incubated for 3 h at 37°C in a
humidified CO2 incubator to allow for cell attachment, after which
the cultures were supplied with 2 ml of medium [F12 supple-
mented with 10% fetal bovine serum (FBS) and antibiotics]. Thus,
in these experiments, micromass cultures were exposed to concen-
trated retroviral vectors for 3 h during the initial plating and
attachment of the cells.
In subsequent experiments, standard micromass cultures were
established in the wells of 24-well tissue culture dishes, and
cultured for 24 h in 1 ml of standard F12 medium containing 10%
FBS. At 24 h of culture, the medium was removed and replaced
with 200 l of medium containing 20 l of concentrated retrovirus
stock and 2 l of polybrene. After 5 h incubation at 37°C, the
virus-containing medium was removed, and replaced with 1 ml of
fresh F12 medium containing 10% FBS. Thus, in these experi-
ments, micromass cultures were exposed to the retroviral vectors
for 5 h at the beginning of the second day of culture.
The morphology of the micromass cultures was monitored
daily by phase microscopy, and the expression of the EGFP
reporter gene of the retroviral constructs was monitored by
fluorescence microscopy. The accumulation of cartilage matrix
was monitored histochemically by staining with Alcian blue, pH
1.0, as previously described (Gay and Kosher, 1984). Total RNA
was prepared from cultures by using the RNeasy Mini kit
(Qiagen), and steady-state levels of transcripts for type II colla-
gen, the core protein of the cartilage proteoglycan aggrecan,
Gdf5, and Wnt14 were determined by dot blot hybridization
using the specific cDNA probes described above and the high-
stringency conditions previously described (Kosher et al.,
1986a,b; Kulyk et al., 1991). Levels of hybridizable RNA se-
quences were determined by densitometry using an Alpha Inno-
tech digital imaging system. The total poly(A) mRNA content
of samples was determined by hybridizing aliquots of the same
samples used for determination of specific mRNA levels with
32P-labeled oligo(dT)20 as described by Harley (1987).
RESULTS
Cux1 Is Highly Expressed at All of the Discrete Sites
of Incipient Joint Formation in the Developing Limb
Concomitant with the Conversion of Differentiated
Chondrocytes into Interzone Tissue
The initial formation of the interzones at the onset of the
segmentation process that generates joints between the
skeletal elements of the embryonic chick limb bud occurs
FIG. 1. Preparation of the Cux1 replication-defective retroviral expression vector. MG-1 is a derivative of the replication-defective vector
LXSN (Miller and Rosman, 1989) into which a CMV promoter and an enhanced green fluorescent protein (EGFP) cDNA had been cloned
upstream of the SV40 promoter and neo gene cassette of the LXSN vector. GL-1 was prepared by excising a fragment containing the EGFP
cDNA, SV40 promoter, and most of the neo gene with AgeI and RsrII. A 4.6-kb cDNA containing the full coding sequence of human Cux1
was cloned by blunt-end ligation into the SalI site of an pIRES2/EGFP vector (Clontech), resulting in a construct containing Cux1 cDNA
upstream of an IRES followed by an EGFP cDNA. The Cux1-IRES-EGFP fragment was excised by digestion with EcoRV and NotI, and
cloned by blunt-end ligation into GL-1 downstream of the CMV promoter. This resulted in a Cux1 retroviral expression vector containing
the CMV promoter upstream of the Cux1 cDNA followed by an IRES and an EGFP cDNA. LTR, retroviral long terminal repeat; p(A),
polyadenylation site. Arrows indicate transcriptional start sites and direction of transcription.
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during stages 27–31. Cux1 expression was examined by
Northern blot analysis of RNA isolated from limb buds at
these stages. As shown in Fig. 2, a 993-bp cDNA fragment
from the 5 end of a chicken EST clone with homology to
mouse and human Cux1 (see Materials and Methods) hy-
bridizes to transcripts of about 12 and 2.8 kb in RNA
isolated from stage 26/27, stage 29, and stage 30 embryonic
chick limb buds. The 12-kb transcript is similar in size to
the full-length Cux1 transcripts containing the homeodo-
main and DNA-binding cut repeats that are detectable in
other vertebrate species (Neufeld et al., 1992; Vanden
Heuvel et al., 1996; Lievens et al., 1997). The 2.8-kb species
corresponds to a highly conserved alternatively spliced
product of the Cux1 gene called CASP that lacks DNA-
binding motifs (Lievens et al., 1997).
The temporal and spatial pattern of Cux1 expression
during the onset of joint formation was examined by in situ
hybridization. Identical expression patterns were detected
by using a probe that hybridizes to both full-length Cux1
transcripts and its conserved alternatively spliced product
CASP and probes that are specific for either full-length
Cux1 or CASP (see Materials and Methods).
As exemplified by the developing elbow joint shown in
Figs. 3A and 3B, the onset of joint formation is character-
ized by the conversion of differentiated chondrocytes that
express high levels of cartilage-characteristic type II colla-
gen into the nonchondrogenic cells of the interzone which
express little type II collagen. At stage 25, before the
formation of the interzone, cartilage differentiation charac-
terized by the expression of type II collagen has occurred
throughout the continuous Y-shaped humerus, radius, and
ulna rudiment, including the site at which the elbow joint
will subsequently form (Fig. 3A). At about stage 27, type II
collagen expression greatly diminishes concomitant with
the formation of the interzone at the presumptive elbow
joint (Fig. 3B). As shown in Fig. 3C, Cux1 is highly ex-
pressed in the developing elbow joint interzone concomi-
tant with the downregulation of type II collagen expression.
During stages 28–35, Cux1 is highly expressed at virtu-
ally all of the discrete sites of incipient joint formation in
the developing limb concomitant with the conversion of
differentiated chondrocytes into interzone tissue (Fig. 4). As
shown in Fig. 4, Cux1 is expressed in the developing
interzones of the presumptive elbow joint (Figs. 4A, 4C, and
4E), the wrist joint (Figs. 4A, 4C, and 4E), the joints that are
forming between the individual carpal bones (Fig. 4E), the
carpometacarpal joints (Figs. 4A, 4C, and 4E), and the
metacarpophalangeal (Fig. 4A) and interphalangeal joints
(Fig. 4G) of each of the digits. The striking localization of
Cux1 expression at sites of joint formation suggests that it
may play an important role in regulating the onset of the
segmentation process that generates joints between the
skeletal elements of the chick limb.
To further investigate the association of Cux1 with the
onset of joint formation, we compared its expression in
adjacent sections of the same limbs with that of Gdf5, a
secreted signaling molecule that has been implicated in the
regulating synovial joint formation (Storm and Kingsley,
1996). As shown in Fig. 4 (E, F and G, H), during stages
28–35, Cux1 and Gdf5 are coexpressed at all of the sites of
incipient joint formation in the developing limb. This
FIG. 2. Northern blot analysis of Cux1 expression in stage 26/27,
stage 29, and stage 30 embryonic chick limb buds. A 993-bp cDNA
fragment from the 5 end of a chicken EST clone with homology to
mouse and human Cux1 (see Materials and Methods) hybridizes to
transcripts of about 12 kb and 2.8 kb in RNA isolated from limb
buds at each stage. The 12-kb transcript is similar in size to the
full-length Cux1 transcripts containing the homeodomain and
DNA-binding cut repeats that are detectable in other vertebrate
species (Neufeld et al., 1992; Vanden Heuvel et al., 1996; Lievens et
al., 1997), and the 2.8-kb species corresponds to a highly conserved
alternatively spliced product of the Cux1 gene called CASP that
lacks DNA-binding motifs (Lievens et al., 1997).
FIG. 3. Expression of Cux1 at the onset of elbow joint formation.
(A) Type II collagen expression in a stage 25 wing bud. Note that
cartilage differentiation characterized by the expression of type II
collagen occurs throughout the continuous Y-shaped humerus,
radius, and ulna rudiment, including the site at which the elbow
joint will subsequently form. (B, C) Type II collagen (B) and Cux1
(C) expression in adjacent sections of the same stage 27 wing bud.
Type II collagen expression greatly decreases concomitant with the
formation of the interzone at the presumptive elbow joint (B), and
Cux1 is expressed in the developing elbow joint interzone con-
comitant with the downregulation of type II collagen expression.
Bar, 200 m.
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provides further support for a role for Cux1 in the regulating
the onset of joint formation, and suggests the possibility
that there may be regulatory relationships between Cux1
and Gdf5 in the process.
Cux1 Suppresses Cartilage Differentiation in Vitro
As described above, Cux1 is highly expressed at all of the
discrete sites of incipient joint formation in the developing
limb where differentiated chondrocytes that stain with
Alcian blue and express high amounts of type II collagen are
being converted into the densely packed cells of the joint
interzone that exhibit little or no Alcian blue staining or
type II collagen expression. This suggests the hypothesis
that Cux1 may be involved in regulating the onset of joint
formation by facilitating the conversion of differentiated
chondrocytes into the nonchondrogenic cells of the joint
interzone. To investigate this possibility further, we wished
to determine whether Cux1 could convert differentiated
limb chondrocytes into nonchondrogenic cells in vitro.
Accordingly, we examined the effect of retroviral misex-
pression of Cux1 on the chondrogenic differentiation of
limb mesenchymal cells in high-density micromass cul-
tures. In these studies, we utilized micromass cultures
prepared from the mesenchymal cells in the distal tip of
stage 25 wing buds, since these cells are a relatively
homogeneous population of undifferentiated chondrogenic
precursors which uniformly progress through the phases of
chondrogenic differentiation in micromass culture and
form a virtually uniform sheet of cartilage with little or no
nonchondrogenic tissue detectable (Gay and Kosher, 1984).
To misexpress Cux1, we used an MoMLV-derived replica-
tion-defective retroviral expression vector containing the
CMV promoter upstream of a cDNA containing the full
coding sequence of human Cux1 followed by an IRES and a
cDNA encoding EGFP which serves as a reporter gene to
monitor the expression of the vector.
In our initial experiments, limb mesenchymal cells in
micromass culture were exposed to concentrated Cux1
retroviral vector or to a control vector expressing EGFP but
lacking the Cux1 cDNA insert for 3 h during the initial
plating and attachment of the cells (see Materials and
Methods). Widespread expression of EGFP detectable by
fluorescence microscopy occurs 15–24 h after this initial
infection period, by which time the cultures will have
initiated deposition of an Alcian blue-stainable cartilage
matrix and upregulated expression of genes for type II
collagen and other cartilage-specific matrix proteins
(Kosher et al., 1986a,b; Kulyk et al., 1991).
As shown in Fig. 5, by day 4 of culture, virtually all of the
cells in the Cux1-infected and control cultures exhibit
EGFP expression (Figs. 5C and 5D). In addition, Cux1
transcripts are expressed at high levels in the Cux1-infected
cultures, but are not expressed in the control cultures
FIG. 4. Expression of Cux1 at all of the discrete sites of incipient joint formation in the developing limb. (A, B and C, D) Cux1 and type
II collagen expression in adjacent sections of the same limbs at stage 28/29 (A, B) and stage 29/30 (C, D). Cux1 is expressed in the interzone
of the developing elbow joint (e), the wrist joint (w), the carpometacarpal joints (cm), and the metacarpophalangeal joints (mp). (E, F) Cux1
and Gdf5 expression in adjacent sections of the same stage 30 limb. Cux1 and Gdf5 are coexpressed at all of the sites of incipient joint
formation, including the elbow joint (e), wrist joint, carpal joints, and carpometacarpal joints. (G, H) Coexpression of Cux and Gdf5 in the
interphalangeal joints in adjacent sections of the same stage 35 limb. Bar, 200 m.
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infected with the retroviral vector expressing EGFP but
lacking the Cux1 cDNA insert (data not shown). On day 4,
the cells of control cultures have uniformly deposited a
refractile extracellular cartilage matrix detectable by phase
microscopy (Fig. 5A). In contrast, relatively little refractile
cartilage matrix is detectable in the Cux1-infected cultures,
but rather large numbers of densely packed apparently
nonchondrogenic cells are present that are not surrounded
by a refractile matrix (Fig. 5B). The suppression of chondro-
genic differentiation detectable by phase microscopy is
reflected in a striking decrease in the accumulation of
Alcian blue-stained cartilage in the Cux1-infected cultures.
As shown in Fig. 5, whereas a uniform, darkly staining
Alcian blue-positive cartilage matrix is present throughout
the control cultures, little or no Alcian blue-staining matrix
is detectable in the Cux1-infected cultures. The suppres-
sion of chondrogenesis in the Cux1-infected cultures de-
tectable by phase microscopy and Alcian blue staining is
accompanied by about a threefold reduction in the steady
state levels of transcripts for cartilage-characteristic type II
collagen and the core protein of the cartilage proteoglycan
aggrecan (Fig. 6). Thus, Cux1 elicits a striking diminution
in Alcian blue staining and downregulation of cartilage-
specific gene expression as occurs at the onset of normal
FIG. 5. Suppression of limb cartilage differentiation in vitro by Cux1. (A, B) Phase photomicrographs of day 4 micromass cultures of limb
mesenchymal cells infected for 3 h at the onset of culture with the Cux1 retroviral expression vector (Cux1-RV) (B) or with a control vector
expressing EGFP but lacking the Cux1 cDNA insert (EGFP-RV) (A). Control cultures have uniformly deposited a refractile pericellular
cartilage matrix (A), whereas relatively little refractile cartilage matrix is detectable in the Cux1 infected cultures, which contain large
numbers of densely packed apparently nonchondrogenic cells. (C, D) EGFP expression detectable by fluorescence microscopy in the
EGFP-RV control (C) and Cux1-infected (D) cultures shown in (A) and (B). EGFP is expressed by virtually all the cells of the control (C) and
Cux1-infected (D) cultures. (E, F) Accumulation of Alcian blue-stainable cartilage matrix by EGFP-RV control (E) and Cux1-infected (F)
cultures. A uniform, darkly staining Alcian blue-positive cartilage matrix is present throughout the control cultures, whereas little Alcian
blue-staining matrix is detectable in the Cux1-infected cultures. Bar, in (A–D), 200 m; in (E, F), 8 mm.
50 Lizarraga et al.
© 2002 Elsevier Science (USA). All rights reserved.
joint formation. The total poly(A) RNA content of Cux1-
infected cultures is 92% (n  4) that of control cultures,
indicating that Cux1 is not a general repressor of transcrip-
tion. Cux1 does not induce the expression of transcripts for
either Gdf5 or Wnt14, signaling molecules that have been
implicated in regulating the onset of joint formation (data
not shown).
In the preceding experiments, the Cux1 retroviral expres-
sion vector was supplied to the limb mesenchymal cells for
a 3-h period at the initiation of culture, which is 15–24 h
before the cells undergo overt chondrogenic differentiation
characterized by deposition of an Alcian blue staining
matrix and upregulation of cartilage-specific gene expres-
sion. Taking into account the time it should take for the
virus to be internalized and integrated into the genome, we
assume it would take 15–24 h for ectopic expression of
Cux1 to occur, which is after overt cartilage differentiation
will have taken place. This is important, since we wanted
to reproduce a situation comparable to that which occurs in
vivo, where, at sites of incipient joint formation, Cux1 is
expressed by chondrocytes after the onset of their differen-
tiation. Although our prediction of the timing of ectopic
Cux1 expression is consistent with the timing of expression
of the EGFP reporter gene (see above), we nevertheless
wanted to be absolutely certain that Cux1 would suppress
cartilage differentiation when expressed after the initiation
of the process. Accordingly, we performed experiments in
which micromass cultures were not supplied with the Cux1
retroviral vector until 24 h after the initiation of culture, by
which time lightly staining Alcian blue cartilage matrix
had already been uniformly deposited by the cultures (see
Fig. 7A). Indeed, in these experiments, Cux1 misexpression
would not be expected to occur until 36–48 h of culture
(i.e., 15–24 h after exposure to the retrovirus), by which
time a uniform darkly staining Alcian blue cartilage matrix
has accumulated (Fig. 7B). As shown in Fig. 7C, micromass
cultures supplied with the control retroviral vector at 24 h
progressively continue to accumulate Alcian blue-stainable
cartilage matrix for the next 3 days. In contrast, 3 days after
being supplied with the Cux1 retroviral vector at 24 h, little
Alcian blue-staining cartilage matrix is detectable (Fig. 7D).
Thus, this experiment clearly demonstrates that Cux1
FIG. 6. Cux1 suppresses cartilage-specific gene expression in
vitro. Relative steady state levels of type II collagen and aggrecan
transcripts in day 4 micromass cultures infected with the Cux1
retroviral expression vector (Cux1-RV) or with the EGFP control
vector (EGFP-RV). The amount of each specific mRNA/total
poly(A) RNA in the Cux1-infected cultures is presented as an
amount relative to that in the EGFP-RV control cultures, which
was arbitrarily set to 100. Values are the means of four determina-
tions  SEM.
FIG. 7. Conversion of differentiated chondrocytes in vitro by
Cux1. (A) A 24-h untreated control micromass culture exhibiting
uniform lightly staining Alcian blue-positive cartilage matrix. This
is the time that cultures were supplied with either the EGFP
control or Cux1 retroviral expression vectors for 5 h. (B) A 48-h
untreated control culture exhibiting a uniform darkly staining
Alcian blue cartilage matrix. This corresponds roughly to the time
at which high expression of Cux1 and/or EGFP would be occurring
when the vectors are supplied at 24 h. (C, D) 96-h cultures that
were supplied with the EGFP control (EGFP-RV) (C) or the Cux1
(Cux1-RV) (D) retroviral vectors at 24 h. The EGFP-RV control
cultures have continued to accumulate Alcian blue-stainable car-
tilage matrix, whereas the Cux1-infected cultures exhibit little
Alcian blue-stainable cartilage matrix. Bar, 7 mm.
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converts differentiated chondrocytes into nonchondrogenic
cells.
DISCUSSION
The Role of Cux1 in Regulation of the Onset
of Joint Formation
Joint formation is one of the fundamental aspects of limb
pattern formation playing a critical role in determining the
size, shape, and number of individual skeletal elements
(Shubin and Alberch, 1986). The segmentation process that
generates joints between the skeletal elements is initiated
by the conversion of differentiated chondrocytes at the sites
of presumptive joint formation into the densely packed
cells of the joint interzone. This conversion is accompanied
by a loss of Alcian blue-staining cartilage matrix at sites of
presumptive joint formation and a downregulation in ex-
pression of cartilage-characteristic type II collagen and
other cartilage-specific genes.
The results of the present study suggest that Cux1, a
homolog of the Drosophila Cut gene which encodes a
transcription factor containing a homeodomain and other
DNA binding motifs, plays an important role in regulating
the onset of joint formation. Cux1 is highly expressed at all
of the discrete sites of incipient joint formation in the
developing limb concomitant with the conversion of differ-
entiated chondrocytes into interzone tissue. Moreover,
misexpression of Cux1 in micromass cultures of limb
mesenchymal cells that had undergone cartilage differen-
tiation results in a conversion of the differentiated chon-
drocytes into densely packed nonchondrogenic cells which
exhibit loss of Alcian blue-stainable cartilage matrix and
downregulation of cartilage-specific gene expression as oc-
curs during the onset of normal joint formation. These
results suggest that Cux1is involved in regulating the onset
of joint formation by facilitating the conversion of differen-
tiated chondrocytes into the nonchondrogenic cells of the
joint interzone.
Significantly, a recent study indicates that expression of
Cux1 can disrupt the differentiation of cartilaginous skel-
etal elements in vivo (Tavares et al., 2000). Adenoviral-
mediated misexpression of Cux1 in the developing chick
limb in ovo results in severe skeletal defects, including an
absence of cartilage elements and gaps and/or severe reduc-
tions in Alcian blue staining (Tavares et al., 2000). Al-
though these effects were suggested to result from impaired
AER activity (Tavares et al., 2000), they are consistent with
our in vitro micromass culture studies demonstrating that
Cux1 misexpression can directly suppress limb cartilage
differentiation.
Mechanism by Which Cux1 May Regulate
the Onset of Joint Formation
A key event in the onset of joint formation is a down-
regulation in the expression of type II collagen and other
cartilage matrix protein genes, such as aggrecan. Signifi-
cantly, this downregulation of cartilage-specific gene ex-
pression correlates with the high level of Cux1 expression
that occurs in the developing interzone at the onset of joint
formation. Furthermore, Cux1 can indeed downregulate
type II collagen and aggrecan transcript expression in limb
chondrocytes in micromass culture. It is therefore notewor-
thy that vertebrate Cux1 homologs, in general, appear to
function as transcriptional repressors, and, in particular,
inhibit expression of tissue-specific genes in multiple lin-
eages. In cotransfection assays, vertebrate Cux1 homologs
repress the activity of promoter/enhancer constructs of
genes for muscle-specific -cardiac myosin heavy chain
(Andres et al., 1992), erthyroid-specific -globin (Superti-
Furga et al., 1989), myeloid-specific cytochrome b heavy
chain (Skalnik et al., 1991), neural-specific NCAM (Val-
arche et al., 1993), and bone-specific osteocalcin (van Gurp
et al., 1999) (see also Higgy et al., 1997; Dufort and Nepveu,
1994; Benan et al., 1997). Thus, it has been suggested that
Cux genes, in general, act as developmentally regulated
repressors of tissue-specific gene expression. Cux1 ho-
mologs can inhibit gene transcription by interfering with
the interaction of tissue-specific transcription activators
with their target sequences (Andres et al., 1992; Mailley et
al., 1996) and can actively repress the transcription of
already active tissue-specific genes (Mailley et al., 1996).
These observations suggest that the primary function of
Cux1 at the onset of joint formation may be to repress the
expression of the type II collagen gene or other cartilage-
specific genes, thus facilitating the formation of the joint
interzone tissue.
Although Cux1 downregulates type II collagen and aggre-
can expression in limb chondrocytes in micromass cul-
tures, it does not induce the expression of either Wnt14 or
Gdf5, signaling molecules that have been implicated in
regulating joint formation (Hartmann and Tabin, 2001;
Storm and Kingsley, 1996; Thomas et al., 1996, 1997). This
suggests the possibility that Cux1 may be a downstream
target gene of these secreted signaling molecules. Alter-
nately, Cux1 might function in an separate or parallel
pathway at the onset of joint formation. It will be of
particular interest to determine whether Cux1 is a down-
stream target of Wnt14 signaling at the onset of joint
formation, since Wnt14, like Cux1, suppresses chondro-
genic differentiation (Hartmann and Tabin, 2001). In any
case, it is likely that Cux1 functions in conjunction with
other signaling molecules and transcription factors which
may regulate various and distinct aspects of joint forma-
tion. In particular, Cux1 may function by repressing the
expression of cartilage-specific genes, while other factors,
such as Wnt14 and/or Gdf5, may act as positive regulators
of the expression of markers of early joint formation.
Understanding the precise roles and relationships between
Cux1 and other factors in the regulation of joint formation
will require considerable further investigation.
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SUMMARY
The results of this study suggest that the homeodomain-
containing transcription factor Cux1 plays an important
role in regulating the onset of the segmentation process that
generates joints between the skeletal elements of the devel-
oping limb by facilitating the conversion of differentiated
chondrocytes into the nonchondrogenic cells of the joint
interzone. Understanding the mechanisms and molecules
involved in joint formation during embryonic development
may provide insights into the nature of and possible thera-
peutic treatments for degenerative joint diseases.
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